First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
about
Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICAEfficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: A meta-analysis of prospective studiesChemotherapy for hepatocellular carcinoma: The present and the future.Systemic treatment for hepatocellular carcinoma: Still unmet expectationsHypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells.Management of pediatric hepatocellular carcinoma: A multimodal approach.
P2860
First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@ast
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@en
type
label
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@ast
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@en
prefLabel
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@ast
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@en
P2093
P2860
P1476
First-line gemcitabine and oxa ...... arcinoma: a preliminary study.
@en
P2093
Jufeng Wang
Shuning Xu
P2860
P2888
P304
P356
10.1007/S10147-015-0796-5
P577
2015-02-25T00:00:00Z